Alexza Pharmaceuticals, Inc. (ALXA) Poster Larger than Expected Q3 Loss
Tweet Send to a Friend
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q3 EPS of ($0.72), $0.18 worse than the analyst estimate of ($0.54). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
